Randomized, single-center, open-label safety and pharmacokinetics study of Pirfenidone and its metabolite 5-carboxy-pirfenidone in chinese volunteers in fed condition

Trial Profile

Randomized, single-center, open-label safety and pharmacokinetics study of Pirfenidone and its metabolite 5-carboxy-pirfenidone in chinese volunteers in fed condition

Completed
Phase of Trial: Phase I

Latest Information Update: 20 Oct 2015

At a glance

  • Drugs Pirfenidone (Primary)
  • Indications Idiopathic pulmonary fibrosis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 20 Oct 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top